Target intelligence / Profile preview

Viral RNA replication

Molecular classification
Other
01

Overview

Viral RNA replication refers to the process by which RNA viruses copy their RNA genomes within a host cell. This process relies on enzyme complexes such as the RNA-dependent RNA polymerase (RdRp) for most RNA viruses, or reverse transcriptase for retroviruses[1][2]. During the replication cycle, viral RNA serves as a template for the synthesis of additional genomes (progeny RNA) and for mRNAs required for protein synthesis. The replicase complex, comprising viral proteins such as RdRp, helicases, and sometimes host factors, orchestrates the copying and processing of viral RNA[2][3]. Because this process is essential and virus-specific, several antiviral drugs target the key enzymes (e.g., RdRp), thus blocking viral proliferation. However, "Viral RNA replication" itself is a mechanistic step, not a discrete druggable biomolecule[1][2][4]. Because "Viral RNA replication" is a process not a protein, enzyme, or receptor, it is not a canonical therapeutic target—drugs inhibit specific enzymes involved (such as RdRp), not the process as a whole[2][3]. The proper structured target would be the main viral enzyme (e.g., "RNA-dependent RNA polymerase") for a family or species of interest.

Other names
viral genome replicationRNA virus replicationRNA synthesis (viral)genome replication (virus)
02

Mechanism of action

Inhibition of RNA-dependent RNA polymerase (blocks synthesis of viral RNA) Incorporation of nucleotide analogs to induce chain termination of RNA synthesis

03

Biological functions

Genome replicationExpression of viral genesProduction of viral progeny
04

Disease associations

InfectionViral disease
05

Safety considerations

Broad inhibition of RNA synthesis can cause cytotoxicity if host enzymes are affectedDrug resistance can emerge through mutation of the viral polymeraseOff-target effects and interference with host nucleic acid metabolism
06

Interacting drugs

remdesivir

1 more in the full profile.

07

Biomarkers

No direct biomarkers for "viral RNA replication" as a process; often, viral load or detection of viral RNA by PCR used as surrogate measure

Beyond the preview

Go deeper on Viral RNA replication.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral RNA replication.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call